Defining key concepts of intestinal and epithelial cancer biology through the use of mouse models

Carcinogenesis. 2017 Oct 1;38(10):953-965. doi: 10.1093/carcin/bgx080.

Abstract

Over the past 20 years, huge advances have been made in modelling human diseases such as cancer using genetically modified mice. Accurate in vivo models are essential to examine the complex interaction between cancer cells, surrounding stromal cells, tumour-associated inflammatory cells, fibroblast and blood vessels, and to recapitulate all the steps involved in metastasis. Elucidating these interactions in vitro has inherent limitations, and thus animal models are a powerful tool to enable researchers to gain insight into the complex interactions between signalling pathways and different cells types. This review will focus on how advances in in vivo models have shed light on many aspects of cancer biology including the identification of oncogenes, tumour suppressors and stem cells, epigenetics, cell death and context dependent cell signalling.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • CRISPR-Cas Systems
  • Disease Models, Animal
  • Epithelium / pathology*
  • Genes, Tumor Suppressor
  • Humans
  • Intestinal Neoplasms / genetics
  • Intestinal Neoplasms / metabolism*
  • Intestinal Neoplasms / pathology*
  • Methylation
  • Mice
  • Mice, Transgenic
  • Neoplasms, Experimental / genetics
  • Neoplasms, Experimental / metabolism
  • Neoplasms, Experimental / pathology*
  • Neoplastic Stem Cells / pathology
  • Oncogenes
  • Signal Transduction
  • Stem Cells / metabolism
  • Stem Cells / pathology